Safety and tolerability of pneumococcal vaccines in children.

about

Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines From Immunologically Archaic to Neoteric Glycovaccines.Strategies to develop vaccines of pediatric interest.Development of pneumococcal vaccines over the last 10 years.

P2860

Q28077703-6BD5B12A-4F79-44C5-B056-020F74F611B7 Q30238724-79398A29-2A99-4390-8AE6-17D2D34B5768 Q38819027-C6F73A18-492D-4D78-8E58-28A2F8340752 Q47658958-B5C1A7F6-8EFB-4552-B36F-93BE81B095FC

P2860

Safety and tolerability of pneumococcal vaccines in children.

Item

http://www.wikidata.org/entity/Q38753554

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Safety and tolerability of pneumococcal vaccines in children.

@en

type

Item

label

Safety and tolerability of pneumococcal vaccines in children.

@en

prefLabel

Safety and tolerability of pneumococcal vaccines in children.

@en

P1476

Safety and tolerability of pneumococcal vaccines in children.

@en

P2860

International trends in sudden infant death syndrome: stabilization of rates requires further action.

Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data

Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine.

Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children.

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.

Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.

A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children.

P304

777-785

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2016.1160056

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Susanna Esposito

Nicola Principi

P577

2016-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26923347

http://www.w3.org/2001/XMLSchema#string

Safety and tolerability of pneumococcal vaccines in children.

about

P2860

P2860

Safety and tolerability of pneumococcal vaccines in children.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698